Testing effectiveness (Phase 2)Study completedNCT02425137
What this trial is testing
S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer
Who this might be right for
Advanced Biliary Tract Cancer(BTC)
TTY Biopharm 51